AA-FENO-SUPER: Product Quality
Last updated
Summary
Product
AA-FENO-SUPER
Issue
Health products - Product quality
What to do
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
---|---|---|---|---|---|
AA-FENO-SUPER |
AA-FENO-SUPER |
DIN 02246860 |
Tablet |
Fenofibrate 160mg |
TK2571 |
Issue
Presence of one (1) AA-FENO-SUPER 100 mg tablet in affected lot of AA-FENO-SUPER 160 mg.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers
Details
Original published date: 2022-05-05
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
AA Pharma Inc.
1165 Creditstone Road Unit #1
Vaughan, ON
L4K4N7
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-64145